Evaluate patient background of semaglutide usage and skin symptoms such as paresthesia or sensitivity prior to opting for aggressive protocols
Both medications demonstrated blood pressure reductions in clinical trials beyond what weight loss alone would predict
International Journal of Neuroscience
FDA-approved under Zepbound for weight loss and Mounjaro for diabetes, this medication delivers some of the highest success rates in clinical weight management, with patients often losing 1520% or more of their starting weight
The FDA maintains a list of substances allowed to be compounded by outsourcing facilities as part of the 503B drug program, and its looking to exclude semaglutide, tirzepatide and liraglutidepopular weight loss drugsas part of a crackdown on the online availability of these drugs, all part of the larger GLP-1 market
GHK-Cu dosing protocols frequently run for extended periods weeks to months because the tissue regeneration, skin research, and anti-aging biomarker effects develop slowly